TB status in a dynamic cohort of patients with Inflammatory Bowel Disease receiving immunosuppression treatment, with up to 8 years of follow-up.

M. Arias Guillen (Oviedo, Spain), R. De Francisco (Oviedo, Spain), S. Riestra-Menéndez (Oviedo, Spain), G. Muñiz-Albaiceta (Oviedo, Spain), M. González-Budiño (Oviedo, Spain), M. García-Clemente (Oviedo, Spain), C. Del Busto (Oviedo, Spain), M. Santibáñez-Margüello (Santander, Spain), A. Castaño-García (Oviedo, Spain), S. Martínez-González (Oviedo, Spain), C. Huidobro (Oviedo, Spain), L. Pérez-González (Oviedo, Spain), I. Ruiz-Alvarez (Oviedo, Spain), J. Herrero-Huertas (Oviedo, Spain), P. Ugarriza (Oviedo, Spain), V. Jiménez-Beltrán (Oviedo, Spain), P. Flórez-Díez (Oviedo, Spain), N. Rodríguez (Oviedo, Spain), C. Bailón (Oviedo, Spain), S. Gómez-Mañas (Oviedo, Spain), A. Losada-Dieguez (Oviedo, Spain), P. Escalante (Ro,MN, United States of America)

Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection I
Session: Tuberculosis and non-TB mycobacterial infection I
Session type: Oral Presentation
Number: 3818
Disease area: Respiratory infections

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Arias Guillen (Oviedo, Spain), R. De Francisco (Oviedo, Spain), S. Riestra-Menéndez (Oviedo, Spain), G. Muñiz-Albaiceta (Oviedo, Spain), M. González-Budiño (Oviedo, Spain), M. García-Clemente (Oviedo, Spain), C. Del Busto (Oviedo, Spain), M. Santibáñez-Margüello (Santander, Spain), A. Castaño-García (Oviedo, Spain), S. Martínez-González (Oviedo, Spain), C. Huidobro (Oviedo, Spain), L. Pérez-González (Oviedo, Spain), I. Ruiz-Alvarez (Oviedo, Spain), J. Herrero-Huertas (Oviedo, Spain), P. Ugarriza (Oviedo, Spain), V. Jiménez-Beltrán (Oviedo, Spain), P. Flórez-Díez (Oviedo, Spain), N. Rodríguez (Oviedo, Spain), C. Bailón (Oviedo, Spain), S. Gómez-Mañas (Oviedo, Spain), A. Losada-Dieguez (Oviedo, Spain), P. Escalante (Ro,MN, United States of America). TB status in a dynamic cohort of patients with Inflammatory Bowel Disease receiving immunosuppression treatment, with up to 8 years of follow-up.. 3818

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Risk factors for active tuberculosis in patients with inflammatory bowel disease: A case-control study
Source: International Congress 2015 – Latent TB infection and screening
Year: 2015


Disease progression at 12 months does not predict future outcomes in IPF patients: Analysis from the Australian IPF Registry
Source: International Congress 2017 – ILDs: clinical aspects
Year: 2017

Systemic inflammatory response during one year follow-up in patients with COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 13s
Year: 2004

Disease activity in long-term survivors of COPD: 10-years’ follow-up data from the Hokkaido COPD cohort study
Source: International Congress 2017 – Current challenges in COPD evaluation
Year: 2017

Asthma severity and diagnostic assessment in subjects older than 40 years in a 12-months cohort of patients referred to a tertiary asthma clinic
Source: Annual Congress 2013 –Disease control and quality of life in airway diseases
Year: 2013

What are reasons for non-adherence in patients with asthma? A 24 weeks prospective telephone follow-up research
Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease
Year: 2013

Causes of death in COPD patients in primary care setting - 6 years follow-up
Source: International Congress 2014 – Prevalence of COPD and mortality from COPD
Year: 2014

Disease characteristics and outcomes in a Swedish cohort of patients with pulmonary fibrosis (PF)
Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs)
Year: 2018


Does smoking status at time of diagnosis of lung cancer independently predict survival at 6 months?
Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours
Year: 2014


Treatment outcomes of tuberculosis patients under directly observed therapy (DOT) for three years
Source: Eur Respir J 2004; 24: Suppl. 48, 653s
Year: 2004

Advanced pulmonary sarcoidosis: long-term follow-up of 10 years or more.
Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes
Year: 2018




Outcomes of patients over eighty years old in intensive care unit: Twelve month cohort study
Source: International Congress 2014 – Best posters in chronic care
Year: 2014


Clinical trials for elderly patients with multiple diseases (CHROMED): A pilot study
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014

The effectiveness of plasmaferesis in patients with relapsing and progressing course of pulmonary sarcoidosis (5 years follow-up)
Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease
Year: 2010


Mortality predictive factors in COPD patients after a pulmonary rehabilitation programme - a 3 years study
Source: International Congress 2014 – Best posters in pulmonary rehabilitation 1
Year: 2014


Clinical characteristics and treatment outcomes of patients with pulmonary tuberculosis with delayed conversion over 4 months
Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes
Year: 2015

Five-year follow-up of subjects diagnosed with COPD in a South African burden of obstructive lung disease (BOLD) survey
Source: International Congress 2014 – Longitudinal studies of respiratory disease
Year: 2014

Disease burden in COPD patients in the first 24 months following diagnosis in a UK primary care setting
Source: Annual Congress 2013 –Risk factors for COPD and lung function decline
Year: 2013

Risk factors for chronic non-specific cough in 0-2 year olds: A cohort study
Source: International Congress 2015 – Early life matters: prematurity and risk factors for asthma
Year: 2015


Risk factors associated to COPD worsening in Italian general practices: The 12 month COMODHES follow-up study
Source: International Congress 2014 – Prevalence of COPD and mortality from COPD
Year: 2014